Texas Senate Passes Medical Marijuana Expansion Bill

The Texas Senate has passed a bill to expand the state’s medical marijuana program, with amendments that restore chronic pain as a qualifying condition and allow dispensaries to open satellite locations. The measure would add more dispensaries and expand the list of qualifying conditions to include chronic pain, while also allowing medical marijuana for end-of-life … Read more

Tesla Sales Plummet in Europe Amid Decline of EV Market

Tesla’s sales have continued to decline in Europe, with new figures showing a 49.5% drop in April compared to the same period last year. The European Automobile Manufacturers’ Association reports that Chinese competitor BYD has overtaken Tesla as the top-selling electric vehicle (EV) brand in Europe for the first time. According to Jato Dynamics research … Read more

Instagram Fixes Battery Drain Issue on Pixel Phones

Google has confirmed that the recent battery drain issues on Pixel phones are being addressed by Instagram. The social media platform has rolled out an update to fix the problem, available now in version 382.0.0.49.84 from Google Play. Users can check their app’s version number by long-pressing the Instagram app and tapping “App info.” This … Read more

Google Blocks IP with High Request Volume

A user’s IP address, 37.27.54.14, has been flagged by Google due to an excessive number of requests made in a short period. The specific details surrounding this incident are not publicly available. According to reports from Google, high request volumes can be indicative of various issues such as automated script abuse or hacking attempts. In … Read more

Stealth BioTherapeutics Seeks Resubmission After FDA Rejection

Stealth BioTherapeutics said the FDA rejected its Barth syndrome drug elamipretide due to concerns over safety and efficacy. The company will resubmit its application, which could lead to accelerated approval. Source: https://endpts.com/fda-rejects-stealths-rare-disease-drug-but-offers-potential-for-accelerated-approval

US Faces Deadly Nitrous Oxide Epidemic as Sales Rise

Nitrous oxide, commonly known as “laughing gas,” has been linked to a growing number of deaths in the United States. The substance, often used recreationally, is now being sold in smoke shops and online, making it easily accessible to young people. Experts warn that this perfect storm of accessibility and marketing is fueling an addiction … Read more

Perplexity Unveils AI-Powered Lab Tool for Pro Users

Perplexity, the rival search engine to Google, has launched Perplexity Labs, a new tool for its Pro subscribers that can create reports, spreadsheets, dashboards, and more. The platform is available on web, iOS, Android, and soon to be added to Mac and Windows apps. Perplexity claims that Perplexity Labs can help users complete various projects … Read more

Apple to Simplify Operating System Naming Convention

Apple plans to rename its operating systems by year, starting from the update after iOS 18, which will be named iOS 26 instead of a traditional incremental update like iOS 19. This change aims to provide clearer and more consistent branding across Apple’s products, including iPadOS, macOS, watchOS, tvOS, and visionOS. The new naming convention … Read more

9,000 Asus Routers Compromised by Persistent Botnet Attack

A recent attack has compromised over 9,000 Asus routers worldwide, leaving them vulnerable to a persistent botnet threat. The attack, discovered by cybersecurity firm GreyNoise, exploits authentication and router features to gain long-term access. The attackers use official Asus router features to enable SSH on a non-standard port (TCP 53282), allowing remote administrative control. The … Read more

Yahoo-konsernin brändi on muuttunut

Yahoo-konserni on vaihtanut nimensä, ja sen brändi on muuttunut samalla. Konsernin omistamissa sivustoissa ja sovelluksissa näkyvän nimen sijaan käytetään nykyisin usein virallista brändinimiä. Konserniin kuuluvat sivustot Yahoo, AOL, Engadget, Rivals, In The Know sekä Makers. Tähän yhteydessä on ilmoitettu käyttävän evästeitä ja henkilötietoja lisäämiseksi. Jos haluat hylkää tällaiset toimintatavat, voit tehdä valintoja sivustollamme ja sovelluksissamme. … Read more